Marina Chernova

Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis

BACKGROUND: One of the new promising methods of treatment of patients with ulcerative colitis (UC) is biological therapy using bone marrow mesenchymal stromal cells (MCS).

Marina Chernova ;

Oleg Knyazev ;

Sergey Khomeriki ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Mariya Zvyaglova ;

11/20/2018

Comparative frequency of Clostridial infection in patients with ulcerative colitis receiving mesenchymal stromal cells and biological preparations

BACKGROUND: Patients with inflammatory bowel disease (IBD) experienced more frequent development of Clostridial infection and much higher rates of morbidity and mortality compared to pati...

Anna Kagramanova ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Marina Chernova ;

Oleg Knyazev ;

11/20/2018